Surmodics, Inc. (SRDX) gains 1.49% for July 21

Equities Staff  |

Surmodics, Inc. (NASDAQ: SRDX) shares gained 1.49%, or $0.8 per share, to close Wednesday at $54.69. After opening the day at $54.31, shares of Surmodics, fluctuated between $55.21 and $53.76. 24,673 shares traded hands a decrease from their 30 day average of 38,042. Wednesday's activity brought Surmodics,’s market cap to $758,440,920.

Surmodics, is headquartered in Eden Prairie, Minnesota..

About Surmodics, Inc.

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company's expertise in proprietary surface technologies, along with enhanced device design, development, and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit The content of Surmodics' website is not part of this press release or part of any filings that the company makes with the SEC.

Visit Surmodics, Inc.’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Surmodics, Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: Surmodics, Inc.’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Market Movers

Sponsored Financial Content